APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Testing Services

Pharmaceutical Testing Service is often used to identify the chemical composition and molecular structure of each individual substance contained in a medication.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Pharmaceutical Testing Service is often used to identify the chemical composition and molecular structure of each individual substance contained in a medication.

This knowledge provides insight into a drug's performance and safety considerations. Pharmaceutical testing can reveal a pharmaceutical's solubility and can predict the medication's ability to reach a specific target within the body. Testing may even reveal contamination in the manufacturing production process or highlight other, previously unknown risks with the formulation.

Pharmaceutical Testing Services include raw materials testing, in-process and product release testing, finished pharmaceutical products testing and environmental samples, etc. It is mainly used in analytical testing, method development, stability testing and so on, the end users are like pharmaceutical factory, medical institution, government of health department, etc.

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Testing Services Market Outlook and Growth Opportunities 2026

Report ID 173895210421 December 2025212 pages

Choose your research edition.

Industry ResearchPharmaceutical Testing Services Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Testing Services Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Testing Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Testing Services Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Testing Services Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

Pharmaceutical Testing Service is often used to identify the chemical composition and molecular structure of each individual substance contained in a medication.

This knowledge provides insight into a drug's performance and safety considerations. Pharmaceutical testing can reveal a pharmaceutical's solubility and can predict the medication's ability to reach a specific target within the body. Testing may even reveal contamination in the manufacturing production process or highlight other, previously unknown risks with the formulation.

Pharmaceutical Testing Services include raw materials testing, in-process and product release testing, finished pharmaceutical products testing and environmental samples, etc. It is mainly used in analytical testing, method development, stability testing and so on, the end users are like pharmaceutical factory, medical institution, government of health department, etc.

Read the full market overview

Eurofins, WuXi AppTec, Pace Analytical Services, Catalent, Envigo, PPD, Element (Exova), ALS Pharmaceutical, Intertek Group, SGS, Boston Analytical and EAG are the key manufacturters of Pharmaceutical Testing Services. Eurofins is the leader of it by 21% market shares.

USA market took up about 39% the global market, while EU and China were about 3%, 8%.

This report provides an overview of the global Pharmaceutical Testing Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Testing Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Testing Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical Testing Services market.

Pharmaceutical Testing Services Segment by Company

Eurofins

WuXi AppTec

Pace Analytical Services

Catalent

Envigo

PPD

Element (Exova)

ALS Pharmaceutical

Intertek Group

SGS

Boston Analytical

EAG

DYNALABS

Maxxam

ARLBioPharma

West Pharmaceutical

BioScreen

Microbac

RD Laboratories

Analytical Lab Group

Piramal Pharma Solutions

Pharmaceutical Testing Services Segment by Type

Raw Materials Testing

In-Process and Product Release Testing

Finished Pharmaceutical Products Testing

Environmental Samples

Others

Pharmaceutical Testing Services Segment by Application

Analytical Testing

Method Development

Stability Testing

Pharmaceutical Testing Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical Testing Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmaceutical Testing Services key companies, revenue, market share, and recent developments.

3. To split the Pharmaceutical Testing Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmaceutical Testing Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Testing Services significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Testing Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Testing Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Testing Services industry.

Chapter 3: Detailed analysis of Pharmaceutical Testing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmaceutical Testing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmaceutical Testing Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Testing Services Industry Trends Table 2. Pharmaceutical Testing Services Industry Drivers Table 3. Pharmaceutical Testing Services Industry Opportunities and Challenges Table 4. Pharmaceutical Testing Services Industry Restraints Table 5. Global Pharmaceutical Testing Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Testing Services Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Testing Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmaceutical Testing Services Key Company Manufacturing Base & Headquarters Table 9. Global Pharmaceutical Testing Services Company, Product Type & Application Table 10. Global Pharmaceutical Testing Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmaceutical Testing Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Raw Materials Testing Table 15. Significant Companies of In-Process and Product Release Testing Table 16. Significant Companies of Finished Pharmaceutical Products Testing Table 17. Significant Companies of Environmental Samples Table 18. Significant Companies of Others Table 19. Global Pharmaceutical Testing Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Pharmaceutical Testing Services Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Pharmaceutical Testing Services Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Pharmaceutical Testing Services Sales Value Share by Type (2021-2026) Table 23. Global Pharmaceutical Testing Services Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Analytical Testing Table 25. Significant Companies of Method Development Table 26. Significant Companies of Stability Testing Table 27. Global Pharmaceutical Testing Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Pharmaceutical Testing Services Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Pharmaceutical Testing Services Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Pharmaceutical Testing Services Sales Value Share by Application (2021-2026) Table 31. Global Pharmaceutical Testing Services Sales Value Share by Application (2027-2032) Table 32. Global Pharmaceutical Testing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Pharmaceutical Testing Services Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Pharmaceutical Testing Services Sales Value Share by Region (2021-2026) Table 35. Global Pharmaceutical Testing Services Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Pharmaceutical Testing Services Sales Value Share by Region (2027-2032) Table 37. Global Pharmaceutical Testing Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Pharmaceutical Testing Services Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Pharmaceutical Testing Services Sales Value Market Share by Country (2021-2026) Table 40. Global Pharmaceutical Testing Services Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Pharmaceutical Testing Services Sales Value Market Share by Country (2027-2032) Table 42. Eurofins Company Information Table 43. Eurofins Business Overview Table 44. Eurofins Pharmaceutical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Eurofins Pharmaceutical Testing Services Product Portfolio Table 46. Eurofins Recent Development Table 47. WuXi AppTec Company Information Table 48. WuXi AppTec Business Overview Table 49. WuXi AppTec Pharmaceutical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. WuXi AppTec Pharmaceutical Testing Services Product Portfolio Table 51. WuXi AppTec Recent Development Table 52. Pace Analytical Services Company Information Table 53. Pace Analytical Services Business Overview Table 54. Pace Analytical Services Pharmaceutical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Pace Analytical Services Pharmaceutical Testing Services Product Portfolio Table 56. Pace Analytical Services Recent Development Table 57. Catalent Company Information Table 58. Catalent Business Overview Table 59. Catalent Pharmaceutical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Catalent Pharmaceutical Testing Services Product Portfolio Table 61. Catalent Recent Development Table 62. Envigo Company Information Table 63. Envigo Business Overview Table 64. Envigo Pharmaceutical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Envigo Pharmaceutical Testing Services Product Portfolio Table 66. Envigo Recent Development Table 67. PPD Company Information Table 68. PPD Business Overview Table 69. PPD Pharmaceutical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. PPD Pharmaceutical Testing Services Product Portfolio Table 71. PPD Recent Development Table 72. Element (Exova) Company Information Table 73. Element (Exova) Business Overview Table 74. Element (Exova) Pharmaceutical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Element (Exova) Pharmaceutical Testing Services Product Portfolio Table 76. Element (Exova) Recent Development Table 77. ALS Pharmaceutical Company Information Table 78. ALS Pharmaceutical Business Overview Table 79. ALS Pharmaceutical Pharmaceutical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. ALS Pharmaceutical Pharmaceutical Testing Services Product Portfolio Table 81. ALS Pharmaceutical Recent Development Table 82. Intertek Group Company Information Table 83. Intertek Group Business Overview Table 84. Intertek Group Pharmaceutical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Intertek Group Pharmaceutical Testing Services Product Portfolio Table 86. Intertek Group Recent Development Table 87. SGS Company Information Table 88. SGS Business Overview Table 89. SGS Pharmaceutical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. SGS Pharmaceutical Testing Services Product Portfolio Table 91. SGS Recent Development Table 92. Boston Analytical Company Information Table 93. Boston Analytical Business Overview Table 94. Boston Analytical Pharmaceutical Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Boston Analytical Pharmaceutical Testing Services Product Portfolio Table 96. Boston Analytical Recent Development Table 97. EAG Company Information Table 98. EAG Business Overview Table 99. EAG Pharmaceutical Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. EAG Pharmaceutical Testing Services Product Portfolio Table 101. EAG Recent Development Table 102. DYNALABS Company Information Table 103. DYNALABS Business Overview Table 104. DYNALABS Pharmaceutical Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. DYNALABS Pharmaceutical Testing Services Product Portfolio Table 106. DYNALABS Recent Development Table 107. Maxxam Company Information Table 108. Maxxam Business Overview Table 109. Maxxam Pharmaceutical Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Maxxam Pharmaceutical Testing Services Product Portfolio Table 111. Maxxam Recent Development Table 112. ARLBioPharma Company Information Table 113. ARLBioPharma Business Overview Table 114. ARLBioPharma Pharmaceutical Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. ARLBioPharma Pharmaceutical Testing Services Product Portfolio Table 116. ARLBioPharma Recent Development Table 117. West Pharmaceutical Company Information Table 118. West Pharmaceutical Business Overview Table 119. West Pharmaceutical Pharmaceutical Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. West Pharmaceutical Pharmaceutical Testing Services Product Portfolio Table 121. West Pharmaceutical Recent Development Table 122. BioScreen Company Information Table 123. BioScreen Business Overview Table 124. BioScreen Pharmaceutical Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. BioScreen Pharmaceutical Testing Services Product Portfolio Table 126. BioScreen Recent Development Table 127. Microbac Company Information Table 128. Microbac Business Overview Table 129. Microbac Pharmaceutical Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Microbac Pharmaceutical Testing Services Product Portfolio Table 131. Microbac Recent Development Table 132. RD Laboratories Company Information Table 133. RD Laboratories Business Overview Table 134. RD Laboratories Pharmaceutical Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. RD Laboratories Pharmaceutical Testing Services Product Portfolio Table 136. RD Laboratories Recent Development Table 137. Analytical Lab Group Company Information Table 138. Analytical Lab Group Business Overview Table 139. Analytical Lab Group Pharmaceutical Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Analytical Lab Group Pharmaceutical Testing Services Product Portfolio Table 141. Analytical Lab Group Recent Development Table 142. Piramal Pharma Solutions Company Information Table 143. Piramal Pharma Solutions Business Overview Table 144. Piramal Pharma Solutions Pharmaceutical Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Piramal Pharma Solutions Pharmaceutical Testing Services Product Portfolio Table 146. Piramal Pharma Solutions Recent Development Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Pharmaceutical Testing Services Product Image Figure 2. Global Pharmaceutical Testing Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Testing Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Testing Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Raw Materials Testing Image Figure 8. In-Process and Product Release Testing Image Figure 9. Finished Pharmaceutical Products Testing Image Figure 10. Environmental Samples Image Figure 11. Others Image Figure 12. Global Pharmaceutical Testing Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Pharmaceutical Testing Services Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Pharmaceutical Testing Services Sales Value Share by Type (2021-2032) Figure 15. Analytical Testing Image Figure 16. Method Development Image Figure 17. Stability Testing Image Figure 18. Global Pharmaceutical Testing Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Pharmaceutical Testing Services Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Pharmaceutical Testing Services Sales Value Share by Application (2021-2032) Figure 21. Global Pharmaceutical Testing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Pharmaceutical Testing Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Pharmaceutical Testing Services Sales Value (2021-2032) & (US$ Million) Figure 24. North America Pharmaceutical Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Pharmaceutical Testing Services Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Pharmaceutical Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Pharmaceutical Testing Services Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Pharmaceutical Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Pharmaceutical Testing Services Sales Value (2021-2032) & (US$ Million) Figure 30. South America Pharmaceutical Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Pharmaceutical Testing Services Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Pharmaceutical Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Raw Materials Testing
  • In-Process and Product Release Testing
  • Finished Pharmaceutical Products Testing
  • Environmental Samples
  • Others
Applications
  • Analytical Testing
  • Method Development
  • Stability Testing
Companies covered
  • Eurofins
  • WuXi AppTec
  • Pace Analytical Services
  • Catalent
  • Envigo
  • PPD
  • Element (Exova)
  • ALS Pharmaceutical
  • Intertek Group
  • SGS
  • Boston Analytical
  • EAG
  • DYNALABS
  • Maxxam
  • ARLBioPharma
  • West Pharmaceutical
  • BioScreen
  • Microbac
  • RD Laboratories
  • Analytical Lab Group
  • Piramal Pharma Solutions

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical Testing Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical Testing Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmaceutical Testing Services Market Dynamics
  1. 2.1 Pharmaceutical Testing Services Industry Trends
  2. 2.2 Pharmaceutical Testing Services Industry Drivers
  3. 2.3 Pharmaceutical Testing Services Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Testing Services Industry Restraints
3 Pharmaceutical Testing Services Market by Company
  1. 3.1 Global Pharmaceutical Testing Services Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Testing Services Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Testing Services Company Ranking (2024-2026)
  4. 3.4 Global Pharmaceutical Testing Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmaceutical Testing Services Company Product Type and Application
  6. 3.6 Global Pharmaceutical Testing Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmaceutical Testing Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmaceutical Testing Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical Testing Services Market by Type
  1. 4.1 Pharmaceutical Testing Services Type Introduction
  2. 4.1.1 Raw Materials Testing
  3. 4.1.2 In-Process and Product Release Testing
  4. 4.1.3 Finished Pharmaceutical Products Testing
  5. 4.1.4 Environmental Samples
  6. 4.1.5 Others
  7. 4.2 Global Pharmaceutical Testing Services Sales Value by Type
  8. 4.2.1 Global Pharmaceutical Testing Services Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Pharmaceutical Testing Services Sales Value by Type (2021-2032)
  10. 4.2.3 Global Pharmaceutical Testing Services Sales Value Share by Type (2021-2032)
5 Pharmaceutical Testing Services Market by Application
  1. 5.1 Pharmaceutical Testing Services Application Introduction
  2. 5.1.1 Analytical Testing
  3. 5.1.2 Method Development
  4. 5.1.3 Stability Testing
  5. 5.2 Global Pharmaceutical Testing Services Sales Value by Application
  6. 5.2.1 Global Pharmaceutical Testing Services Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmaceutical Testing Services Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pharmaceutical Testing Services Sales Value Share by Application (2021-2032)
6 Pharmaceutical Testing Services Regional Value Analysis
  1. 6.1 Global Pharmaceutical Testing Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Testing Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Testing Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Testing Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical Testing Services Sales Value (2021-2032)
  7. 6.3.2 North America Pharmaceutical Testing Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmaceutical Testing Services Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmaceutical Testing Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmaceutical Testing Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmaceutical Testing Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmaceutical Testing Services Sales Value (2021-2032)
  16. 6.6.2 South America Pharmaceutical Testing Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmaceutical Testing Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmaceutical Testing Services Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Testing Services Country-level Value Analysis
  1. 7.1 Global Pharmaceutical Testing Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Testing Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmaceutical Testing Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmaceutical Testing Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmaceutical Testing Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmaceutical Testing Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmaceutical Testing Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eurofins
  2. 8.1.1 Eurofins Company Information
  3. 8.1.2 Eurofins Business Overview
  4. 8.1.3 Eurofins Pharmaceutical Testing Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eurofins Pharmaceutical Testing Services Product Portfolio
  6. 8.1.5 Eurofins Recent Developments
  7. 8.2 WuXi AppTec
  8. 8.2.1 WuXi AppTec Company Information
  9. 8.2.2 WuXi AppTec Business Overview
  10. 8.2.3 WuXi AppTec Pharmaceutical Testing Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 WuXi AppTec Pharmaceutical Testing Services Product Portfolio
  12. 8.2.5 WuXi AppTec Recent Developments
  13. 8.3 Pace Analytical Services
  14. 8.3.1 Pace Analytical Services Company Information
  15. 8.3.2 Pace Analytical Services Business Overview
  16. 8.3.3 Pace Analytical Services Pharmaceutical Testing Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pace Analytical Services Pharmaceutical Testing Services Product Portfolio
  18. 8.3.5 Pace Analytical Services Recent Developments
  19. 8.4 Catalent
  20. 8.4.1 Catalent Company Information
  21. 8.4.2 Catalent Business Overview
  22. 8.4.3 Catalent Pharmaceutical Testing Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Catalent Pharmaceutical Testing Services Product Portfolio
  24. 8.4.5 Catalent Recent Developments
  25. 8.5 Envigo
  26. 8.5.1 Envigo Company Information
  27. 8.5.2 Envigo Business Overview
  28. 8.5.3 Envigo Pharmaceutical Testing Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Envigo Pharmaceutical Testing Services Product Portfolio
  30. 8.5.5 Envigo Recent Developments
  31. 8.6 PPD
  32. 8.6.1 PPD Company Information
  33. 8.6.2 PPD Business Overview
  34. 8.6.3 PPD Pharmaceutical Testing Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PPD Pharmaceutical Testing Services Product Portfolio
  36. 8.6.5 PPD Recent Developments
  37. 8.7 Element (Exova)
  38. 8.7.1 Element (Exova) Company Information
  39. 8.7.2 Element (Exova) Business Overview
  40. 8.7.3 Element (Exova) Pharmaceutical Testing Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Element (Exova) Pharmaceutical Testing Services Product Portfolio
  42. 8.7.5 Element (Exova) Recent Developments
  43. 8.8 ALS Pharmaceutical
  44. 8.8.1 ALS Pharmaceutical Company Information
  45. 8.8.2 ALS Pharmaceutical Business Overview
  46. 8.8.3 ALS Pharmaceutical Pharmaceutical Testing Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ALS Pharmaceutical Pharmaceutical Testing Services Product Portfolio
  48. 8.8.5 ALS Pharmaceutical Recent Developments
  49. 8.9 Intertek Group
  50. 8.9.1 Intertek Group Company Information
  51. 8.9.2 Intertek Group Business Overview
  52. 8.9.3 Intertek Group Pharmaceutical Testing Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Intertek Group Pharmaceutical Testing Services Product Portfolio
  54. 8.9.5 Intertek Group Recent Developments
  55. 8.10 SGS
  56. 8.10.1 SGS Company Information
  57. 8.10.2 SGS Business Overview
  58. 8.10.3 SGS Pharmaceutical Testing Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 SGS Pharmaceutical Testing Services Product Portfolio
  60. 8.10.5 SGS Recent Developments
  61. 8.11 Boston Analytical
  62. 8.11.1 Boston Analytical Company Information
  63. 8.11.2 Boston Analytical Business Overview
  64. 8.11.3 Boston Analytical Pharmaceutical Testing Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Boston Analytical Pharmaceutical Testing Services Product Portfolio
  66. 8.11.5 Boston Analytical Recent Developments
  67. 8.12 EAG
  68. 8.12.1 EAG Company Information
  69. 8.12.2 EAG Business Overview
  70. 8.12.3 EAG Pharmaceutical Testing Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 EAG Pharmaceutical Testing Services Product Portfolio
  72. 8.12.5 EAG Recent Developments
  73. 8.13 DYNALABS
  74. 8.13.1 DYNALABS Company Information
  75. 8.13.2 DYNALABS Business Overview
  76. 8.13.3 DYNALABS Pharmaceutical Testing Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 DYNALABS Pharmaceutical Testing Services Product Portfolio
  78. 8.13.5 DYNALABS Recent Developments
  79. 8.14 Maxxam
  80. 8.14.1 Maxxam Company Information
  81. 8.14.2 Maxxam Business Overview
  82. 8.14.3 Maxxam Pharmaceutical Testing Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Maxxam Pharmaceutical Testing Services Product Portfolio
  84. 8.14.5 Maxxam Recent Developments
  85. 8.15 ARLBioPharma
  86. 8.15.1 ARLBioPharma Company Information
  87. 8.15.2 ARLBioPharma Business Overview
  88. 8.15.3 ARLBioPharma Pharmaceutical Testing Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 ARLBioPharma Pharmaceutical Testing Services Product Portfolio
  90. 8.15.5 ARLBioPharma Recent Developments
  91. 8.16 West Pharmaceutical
  92. 8.16.1 West Pharmaceutical Company Information
  93. 8.16.2 West Pharmaceutical Business Overview
  94. 8.16.3 West Pharmaceutical Pharmaceutical Testing Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 West Pharmaceutical Pharmaceutical Testing Services Product Portfolio
  96. 8.16.5 West Pharmaceutical Recent Developments
  97. 8.17 BioScreen
  98. 8.17.1 BioScreen Company Information
  99. 8.17.2 BioScreen Business Overview
  100. 8.17.3 BioScreen Pharmaceutical Testing Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 BioScreen Pharmaceutical Testing Services Product Portfolio
  102. 8.17.5 BioScreen Recent Developments
  103. 8.18 Microbac
  104. 8.18.1 Microbac Company Information
  105. 8.18.2 Microbac Business Overview
  106. 8.18.3 Microbac Pharmaceutical Testing Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Microbac Pharmaceutical Testing Services Product Portfolio
  108. 8.18.5 Microbac Recent Developments
  109. 8.19 RD Laboratories
  110. 8.19.1 RD Laboratories Company Information
  111. 8.19.2 RD Laboratories Business Overview
  112. 8.19.3 RD Laboratories Pharmaceutical Testing Services Revenue and Gross Margin (2021-2026)
  113. 8.19.4 RD Laboratories Pharmaceutical Testing Services Product Portfolio
  114. 8.19.5 RD Laboratories Recent Developments
  115. 8.20 Analytical Lab Group
  116. 8.20.1 Analytical Lab Group Company Information
  117. 8.20.2 Analytical Lab Group Business Overview
  118. 8.20.3 Analytical Lab Group Pharmaceutical Testing Services Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Analytical Lab Group Pharmaceutical Testing Services Product Portfolio
  120. 8.20.5 Analytical Lab Group Recent Developments
  121. 8.21 Piramal Pharma Solutions
  122. 8.21.1 Piramal Pharma Solutions Company Information
  123. 8.21.2 Piramal Pharma Solutions Business Overview
  124. 8.21.3 Piramal Pharma Solutions Pharmaceutical Testing Services Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Piramal Pharma Solutions Pharmaceutical Testing Services Product Portfolio
  126. 8.21.5 Piramal Pharma Solutions Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst